The dosage market size value per capita for Penicillins and Streptomycins in Vietnam has demonstrated a steady upward trend from 2013 to 2023. In 2023, the value stood at $2.56 per capita. Marking a consistent increase, the year-on-year growth from 2022 to 2023 was approximately 3.64%, while the previous year realized a growth of around 3.78%. The compound annual growth rate (CAGR) over the last five years was about 3.35%, indicating robust momentum for these antibiotics in the Vietnamese market.
Future trends to watch include:
- An ongoing increase in healthcare awareness, potentially boosting penicillins and streptomycins use.
- Policy changes and healthcare reforms that might impact market dynamics.
- The potential rise of antibiotic resistance influencing prescription and consumption patterns.
| # | 31 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 11.76 | 2023 | View data | ||
| 2 | 2 New Zealand | 11.59 | 2023 | View data | ||
| 3 | 3 France | 11.21 | 2023 | View data | ||
| 4 | 4 Belgium | 11.17 | 2023 | View data | ||
| 5 | 5 United Kingdom | 10.77 | 2023 | View data | ||
| 15 | 15 Poland | 3.78 | 2023 | View data | ||
| 16 | 16 Chile | 3.56 | 2023 | View data | ||
| 17 | 17 Vietnam | 2.56 | 2023 | |||
| 18 | 18 Bolivia | 2.5 | 2023 | View data | ||
| 19 | 19 Peru | 2.49 | 2023 | View data | ||
